China suspends major platform that doubted Beijing COVID policies

Dingxiang Yuan posted articles debunking use of traditional medicine for virus

20220810 DXY

Now-suspended DXY, backed by tech giant Tencent, has at least 30 million followers on China's three major social apps.

CISSY ZHOU, Nikkei staff writer

HONG KONG -- China has suspended a health platform followed by tens of millions that debunked COVID-19 misinformation and criticized the government's boosting of traditional medicine as a treatment for the respiratory illness.

Sponsored Content

About Sponsored ContentThis content was commissioned by Nikkei's Global Business Bureau.